ArticleHuman genomics2020

Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.

Yanhui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.